Obsidian Therapeutics, Inc.
OBX · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Ross Robert W.: Form 4
Insider disclosure · Filed · Report period 03 Aug 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- OBX · 67448A106 - Common Stock, $0.0001 par value per share
Company details and SEC sources
CIK 0002130606 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- OBX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 1030 Massachusetts Avenue, Cambridge, MA, 02138
- Fiscal year end
- 31 December
- Former names on EDGAR
- Gazelle Parent, Inc. (to 03 Aug 2026)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields